
Philippines · Information technology & services startup
Dashlabs.ai is a cloud-based clinic management and laboratory information system (LIS) designed to assist healthcare providers in managing various aspects of patient care.
Funding reportedLast round: Seed
Dashlabs.ai is a cloud-based clinic management and laboratory information system (LIS) designed to assist healthcare providers in managing various aspects of patient care.
The platform streamlines processes such as patient intake, electronic medical records (EMR), results encoding, billing, and reporting, all within a single system. It serves over 350 organizations across Southeast Asia, catering to modern medical institutions of all sizes. The company positions itself as a leading technology provider in the Philippines, focusing on integrated healthcare solutions for both private and public institutions. Dashlabs.ai offers quick deployment to enhance workflow efficiency and reduce costs for labs and healthcare providers. Its services include seamless data management, machine integrations, and PDF certificate generation, making it a comprehensive solution for diagnostic laboratories, medical centers, hospitals, and corporate healthcare providers. The company operates from Mandaluyong City, Philippines, and Palo Alto, California, United States.
Funding, as reported
What they build
Known for
health caresecure data managementelectronic health recordsremote patient onboardingcomputer & network securitycovid-19 testing solutionsradiology information systemlab results reportinginformation technology & servicescontactless registrationhealthcare data securitydata securitydata managementpatient managementhospital & health carehealthcare digital transformation
Built with from their website
Google Tag ManagerCanvaGoogle SheetsAtlassianYouTubeMailChimpGoogle WorkspaceCloudFlareViewport MetaCSS
ZoomdataMongoDBEmotionAmazon Elastic MapReduceGoogle Cloud BigQueryPostgreSQLwebpackMongoDB Atlas
Add your raise, your deck and your story, and put Dashlabs.ai (YC W21) in front of investors. Or tell us what we have wrong.